Industry Research Reports
Home > Reports > Food & Beverages > Human Milk Oligosaccharides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Human Milk Oligosaccharides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Food & Beverages
Published Date: 2025-02-27
Pages: 92 Pages
Report ld: 3570243
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human Milk Oligosaccharides Market Size(US$)
CAGR 2025-2031
3.4%
Market Size,2031
USD 521
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 425 million
Market Forecast in 2031(Value)
US$ 521 million
CAGR
3.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Human Milk Oligosaccharides was estimated to be worth US$ 412 million in 2024 and is forecast to a readjusted size of US$ 521 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Human Milk Oligosaccharides (HMO) are a class of complex carbohydrates naturally found in human breast milk. They are composed of multiple sugar units linked by glycosidic bonds. HMOs are one of the most abundant components in human milk after fat, protein, and lactose, and their concentration is significantly higher in human milk compared to other mammals. HMOs play a crucial role in infant health, serving as prebiotics that promote the growth of beneficial bacteria, such as bifidobacteria, helping to establish a healthy gut microbiome and enhance immune system function.
HMOs vary in structure, including monosaccharides, disaccharides, trisaccharides, and longer polysaccharide chains. Different types of HMOs have distinct biological functions, helping to combat pathogen invasion, reduce inflammation, and support brain development. While HMOs are primarily found in human milk, advances in technology have made it possible to extract and synthesize these oligosaccharides through fermentation and chemical processes for use in commercial products like infant formula, functional foods, and health supplements.
With ongoing research into the benefits of HMOs in infant health and other wellness applications, the demand for human milk oligosaccharides has been steadily increasing, particularly in infant formula and adult prebiotic foods.
Market Development Opportunities and Key Drivers:
As consumer awareness of health increases, especially in regard to infant health, the market for human milk oligosaccharides (HMOs) is experiencing significant growth opportunities. In recent years, extensive research on the role of HMOs in infant health has led more infant formula manufacturers to incorporate HMOs into their products to support immune function and gut health. Additionally, HMOs have shown potential in adult health applications, particularly in maintaining gut microbiome balance and enhancing immune function, opening new growth avenues for the market. As the global population ages and the demand for functional foods rises, there is also growing demand for prebiotic products targeting adults.
Market Risks:
Despite the promising outlook for the HMO market, there are several risks. First, the production of HMOs is complex and costly, which may hinder product accessibility and price competitiveness. Second, the HMO supply chain is intricate, involving multiple stages such as raw material extraction and fermentation. Any technological challenges or disruptions in production could affect the stability of the entire supply chain. Moreover, global regulatory and standard differences may pose challenges to market expansion, particularly in terms of varying regulatory policies and certification requirements in different countries.
Market Concentration:
Currently, the HMO production market is relatively concentrated, with several leading biotech and pharmaceutical companies dominating the industry. These companies have advanced fermentation and biosynthesis technologies that enable large-scale production while maintaining high quality. However, as technology advances and the market expands, more small and medium-sized enterprises are expected to enter the market, fostering competition and innovation.
Downstream Demand Trends:
The downstream demand for HMOs is mainly concentrated in infant formula, prebiotic foods and supplements, and personalized nutrition products. As consumers increasingly demand personalized and functional nutrition products, the market for HMOs as a functional ingredient will continue to grow. Additionally, the potential for HMOs in aging populations is being recognized, particularly for supporting gut health and immune systems in elderly individuals.
Latest Technologies:
The production technology for HMOs is continually evolving, with innovations in fermentation and biosynthesis reducing production costs. Furthermore, the application of genetic engineering and synthetic biology has opened up possibilities for customized HMO production, allowing for optimized efficiency and yields through genetically modified microorganisms.
This report aims to provide a comprehensive presentation of the global market for Human Milk Oligosaccharides, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Milk Oligosaccharides by region & country, by Type, and by Application.
The Human Milk Oligosaccharides market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Milk Oligosaccharides.
MARKET SEGMENTATION
By Company
- Abbott
- Dupont (Inbiose)
- DSM (Glycom)
- Chr. Hansen (Jennewein)
- BASF
- FrieslandCampina
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Fucosyllactose
- LNT & LNNT
- Sialyllactose
Segment by Application
- Infant Formula
- Other Applications
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Milk Oligosaccharides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Milk Oligosaccharides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Milk Oligosaccharides in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Human Milk Oligosaccharides Product Introduction
1.2 Global Human Milk Oligosaccharides Market Size Forecast
1.2.1 Global Human Milk Oligosaccharides Sales Value (2020-2031)
1.2.2 Global Human Milk Oligosaccharides Sales Volume (2020-2031)
1.2.3 Global Human Milk Oligosaccharides Sales Price (2020-2031)
1.3 Human Milk Oligosaccharides Market Trends & Drivers
1.3.1 Human Milk Oligosaccharides Industry Trends
1.3.2 Human Milk Oligosaccharides Market Drivers & Opportunity
1.3.3 Human Milk Oligosaccharides Market Challenges
1.3.4 Human Milk Oligosaccharides Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Milk Oligosaccharides Players Revenue Ranking (2024)
2.2 Global Human Milk Oligosaccharides Revenue by Company (2020-2025)
2.3 Global Human Milk Oligosaccharides Players Sales Volume Ranking (2024)
2.4 Global Human Milk Oligosaccharides Sales Volume by Company Players (2020-2025)
2.5 Global Human Milk Oligosaccharides Average Price by Company (2020-2025)
2.6 Key Manufacturers Human Milk Oligosaccharides Manufacturing Base and Headquarters
2.7 Key Manufacturers Human Milk Oligosaccharides Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Human Milk Oligosaccharides
2.9 Human Milk Oligosaccharides Market Competitive Analysis
2.9.1 Human Milk Oligosaccharides Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Human Milk Oligosaccharides Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Milk Oligosaccharides as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fucosyllactose
3.1.2 LNT & LNNT
3.1.3 Sialyllactose
3.2 Global Human Milk Oligosaccharides Sales Value by Type
3.2.1 Global Human Milk Oligosaccharides Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Human Milk Oligosaccharides Sales Value, by Type (2020-2031)
3.2.3 Global Human Milk Oligosaccharides Sales Value, by Type (%) (2020-2031)
3.3 Global Human Milk Oligosaccharides Sales Volume by Type
3.3.1 Global Human Milk Oligosaccharides Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Human Milk Oligosaccharides Sales Volume, by Type (2020-2031)
3.3.3 Global Human Milk Oligosaccharides Sales Volume, by Type (%) (2020-2031)
3.4 Global Human Milk Oligosaccharides Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Infant Formula
4.1.2 Other Applications
4.2 Global Human Milk Oligosaccharides Sales Value by Application
4.2.1 Global Human Milk Oligosaccharides Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Human Milk Oligosaccharides Sales Value, by Application (2020-2031)
4.2.3 Global Human Milk Oligosaccharides Sales Value, by Application (%) (2020-2031)
4.3 Global Human Milk Oligosaccharides Sales Volume by Application
4.3.1 Global Human Milk Oligosaccharides Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Human Milk Oligosaccharides Sales Volume, by Application (2020-2031)
4.3.3 Global Human Milk Oligosaccharides Sales Volume, by Application (%) (2020-2031)
4.4 Global Human Milk Oligosaccharides Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Human Milk Oligosaccharides Sales Value by Region
5.1.1 Global Human Milk Oligosaccharides Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Human Milk Oligosaccharides Sales Value by Region (2020-2025)
5.1.3 Global Human Milk Oligosaccharides Sales Value by Region (2026-2031)
5.1.4 Global Human Milk Oligosaccharides Sales Value by Region (%), (2020-2031)
5.2 Global Human Milk Oligosaccharides Sales Volume by Region
5.2.1 Global Human Milk Oligosaccharides Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Human Milk Oligosaccharides Sales Volume by Region (2020-2025)
5.2.3 Global Human Milk Oligosaccharides Sales Volume by Region (2026-2031)
5.2.4 Global Human Milk Oligosaccharides Sales Volume by Region (%), (2020-2031)
5.3 Global Human Milk Oligosaccharides Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Human Milk Oligosaccharides Sales Value, 2020-2031
5.4.2 North America Human Milk Oligosaccharides Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Human Milk Oligosaccharides Sales Value, 2020-2031
5.5.2 Europe Human Milk Oligosaccharides Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Human Milk Oligosaccharides Sales Value, 2020-2031
5.6.2 Asia Pacific Human Milk Oligosaccharides Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Human Milk Oligosaccharides Sales Value, 2020-2031
5.7.2 South America Human Milk Oligosaccharides Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human Milk Oligosaccharides Sales Value, 2020-2031
5.8.2 Middle East & Africa Human Milk Oligosaccharides Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Milk Oligosaccharides Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Human Milk Oligosaccharides Sales Value and Sales Volume
6.2.1 Key Countries/Regions Human Milk Oligosaccharides Sales Value, 2020-2031
6.2.2 Key Countries/Regions Human Milk Oligosaccharides Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Human Milk Oligosaccharides Sales Value, 2020-2031
6.3.2 United States Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Human Milk Oligosaccharides Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Human Milk Oligosaccharides Sales Value, 2020-2031
6.4.2 Europe Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Human Milk Oligosaccharides Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Human Milk Oligosaccharides Sales Value, 2020-2031
6.5.2 China Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
6.5.3 China Human Milk Oligosaccharides Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Human Milk Oligosaccharides Sales Value, 2020-2031
6.6.2 Japan Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Human Milk Oligosaccharides Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Human Milk Oligosaccharides Sales Value, 2020-2031
6.7.2 South Korea Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Human Milk Oligosaccharides Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Human Milk Oligosaccharides Sales Value, 2020-2031
6.8.2 Southeast Asia Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Human Milk Oligosaccharides Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Human Milk Oligosaccharides Sales Value, 2020-2031
6.9.2 India Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
6.9.3 India Human Milk Oligosaccharides Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Human Milk Oligosaccharides Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Abbott Human Milk Oligosaccharides Product Offerings
7.1.5 Abbott Recent Development
7.2 Dupont (Inbiose)
7.2.1 Dupont (Inbiose) Company Information
7.2.2 Dupont (Inbiose) Introduction and Business Overview
7.2.3 Dupont (Inbiose) Human Milk Oligosaccharides Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Dupont (Inbiose) Human Milk Oligosaccharides Product Offerings
7.2.5 Dupont (Inbiose) Recent Development
7.3 DSM (Glycom)
7.3.1 DSM (Glycom) Company Information
7.3.2 DSM (Glycom) Introduction and Business Overview
7.3.3 DSM (Glycom) Human Milk Oligosaccharides Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 DSM (Glycom) Human Milk Oligosaccharides Product Offerings
7.3.5 DSM (Glycom) Recent Development
7.4 Chr. Hansen (Jennewein)
7.4.1 Chr. Hansen (Jennewein) Company Information
7.4.2 Chr. Hansen (Jennewein) Introduction and Business Overview
7.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides Product Offerings
7.4.5 Chr. Hansen (Jennewein) Recent Development
7.5 BASF
7.5.1 BASF Company Information
7.5.2 BASF Introduction and Business Overview
7.5.3 BASF Human Milk Oligosaccharides Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 BASF Human Milk Oligosaccharides Product Offerings
7.5.5 BASF Recent Development
7.6 FrieslandCampina
7.6.1 FrieslandCampina Company Information
7.6.2 FrieslandCampina Introduction and Business Overview
7.6.3 FrieslandCampina Human Milk Oligosaccharides Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 FrieslandCampina Human Milk Oligosaccharides Product Offerings
7.6.5 FrieslandCampina Recent Development
8 Industry Chain Analysis
8.1 Human Milk Oligosaccharides Industrial Chain
8.2 Human Milk Oligosaccharides Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Milk Oligosaccharides Sales Model
8.5.2 Sales Channel
8.5.3 Human Milk Oligosaccharides Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Human Milk Oligosaccharides Market Trends
Table 2. Human Milk Oligosaccharides Market Drivers & Opportunity
Table 3. Human Milk Oligosaccharides Market Challenges
Table 4. Human Milk Oligosaccharides Market Restraints
Table 5. Global Human Milk Oligosaccharides Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Human Milk Oligosaccharides Revenue Market Share by Company (2020-2025)
Table 7. Global Human Milk Oligosaccharides Sales Volume by Company (2020-2025) & (K MT)
Table 8. Global Human Milk Oligosaccharides Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Human Milk Oligosaccharides Price by Company (2020-2025) & (USD/MT)
Table 10. Key Manufacturers Human Milk Oligosaccharides Manufacturing Base and Headquarters
Table 11. Key Manufacturers Human Milk Oligosaccharides Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Human Milk Oligosaccharides
Table 13. Global Human Milk Oligosaccharides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Milk Oligosaccharides as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Milk Oligosaccharides Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Human Milk Oligosaccharides Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Human Milk Oligosaccharides Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Human Milk Oligosaccharides Sales Market Share in Value by Type (2020-2025)
Table 20. Global Human Milk Oligosaccharides Sales Market Share in Value by Type (2026-2031)
Table 21. Global Human Milk Oligosaccharides Sales Volume by Type: 2020 VS 2024 VS 2031 (K MT)
Table 22. Global Human Milk Oligosaccharides Sales Volume by Type (2020-2025) & (K MT)
Table 23. Global Human Milk Oligosaccharides Sales Volume by Type (2026-2031) & (K MT)
Table 24. Global Human Milk Oligosaccharides Sales Volume Market Share by Type (2020-2025)
Table 25. Global Human Milk Oligosaccharides Sales Volume Market Share by Type (2026-2031)
Table 26. Global Human Milk Oligosaccharides Price by Type (2020-2025) & (USD/MT)
Table 27. Global Human Milk Oligosaccharides Price by Type (2026-2031) & (USD/MT)
Table 28. Global Human Milk Oligosaccharides Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Human Milk Oligosaccharides Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Human Milk Oligosaccharides Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Human Milk Oligosaccharides Sales Market Share in Value by Application (2020-2025)
Table 32. Global Human Milk Oligosaccharides Sales Market Share in Value by Application (2026-2031)
Table 33. Global Human Milk Oligosaccharides Sales Volume by Application: 2020 VS 2024 VS 2031 (K MT)
Table 34. Global Human Milk Oligosaccharides Sales Volume by Application (2020-2025) & (K MT)
Table 35. Global Human Milk Oligosaccharides Sales Volume by Application (2026-2031) & (K MT)
Table 36. Global Human Milk Oligosaccharides Sales Volume Market Share by Application (2020-2025)
Table 37. Global Human Milk Oligosaccharides Sales Volume Market Share by Application (2026-2031)
Table 38. Global Human Milk Oligosaccharides Price by Application (2020-2025) & (USD/MT)
Table 39. Global Human Milk Oligosaccharides Price by Application (2026-2031) & (USD/MT)
Table 40. Global Human Milk Oligosaccharides Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Human Milk Oligosaccharides Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Human Milk Oligosaccharides Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Human Milk Oligosaccharides Sales Value by Region (2020-2025) & (%)
Table 44. Global Human Milk Oligosaccharides Sales Value by Region (2026-2031) & (%)
Table 45. Global Human Milk Oligosaccharides Sales Volume by Region (K MT): 2020 VS 2024 VS 2031
Table 46. Global Human Milk Oligosaccharides Sales Volume by Region (2020-2025) & (K MT)
Table 47. Global Human Milk Oligosaccharides Sales Volume by Region (2026-2031) & (K MT)
Table 48. Global Human Milk Oligosaccharides Sales Volume by Region (2020-2025) & (%)
Table 49. Global Human Milk Oligosaccharides Sales Volume by Region (2026-2031) & (%)
Table 50. Global Human Milk Oligosaccharides Average Price by Region (2020-2025) & (USD/MT)
Table 51. Global Human Milk Oligosaccharides Average Price by Region (2026-2031) & (USD/MT)
Table 52. Key Countries/Regions Human Milk Oligosaccharides Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Human Milk Oligosaccharides Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Human Milk Oligosaccharides Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Human Milk Oligosaccharides Sales Volume, (2020-2025) & (K MT)
Table 56. Key Countries/Regions Human Milk Oligosaccharides Sales Volume, (2026-2031) & (K MT)
Table 57. Abbott Company Information
Table 58. Abbott Introduction and Business Overview
Table 59. Abbott Human Milk Oligosaccharides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Abbott Human Milk Oligosaccharides Product Offerings
Table 61. Abbott Recent Development
Table 62. Dupont (Inbiose) Company Information
Table 63. Dupont (Inbiose) Introduction and Business Overview
Table 64. Dupont (Inbiose) Human Milk Oligosaccharides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 65. Dupont (Inbiose) Human Milk Oligosaccharides Product Offerings
Table 66. Dupont (Inbiose) Recent Development
Table 67. DSM (Glycom) Company Information
Table 68. DSM (Glycom) Introduction and Business Overview
Table 69. DSM (Glycom) Human Milk Oligosaccharides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. DSM (Glycom) Human Milk Oligosaccharides Product Offerings
Table 71. DSM (Glycom) Recent Development
Table 72. Chr. Hansen (Jennewein) Company Information
Table 73. Chr. Hansen (Jennewein) Introduction and Business Overview
Table 74. Chr. Hansen (Jennewein) Human Milk Oligosaccharides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Chr. Hansen (Jennewein) Human Milk Oligosaccharides Product Offerings
Table 76. Chr. Hansen (Jennewein) Recent Development
Table 77. BASF Company Information
Table 78. BASF Introduction and Business Overview
Table 79. BASF Human Milk Oligosaccharides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. BASF Human Milk Oligosaccharides Product Offerings
Table 81. BASF Recent Development
Table 82. FrieslandCampina Company Information
Table 83. FrieslandCampina Introduction and Business Overview
Table 84. FrieslandCampina Human Milk Oligosaccharides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. FrieslandCampina Human Milk Oligosaccharides Product Offerings
Table 86. FrieslandCampina Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Human Milk Oligosaccharides Downstream Customers
Table 90. Human Milk Oligosaccharides Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Milk Oligosaccharides Product Picture
Figure 2. Global Human Milk Oligosaccharides Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Human Milk Oligosaccharides Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Human Milk Oligosaccharides Sales Volume (2020-2031) & (K MT)
Figure 5. Global Human Milk Oligosaccharides Sales Price (2020-2031) & (USD/MT)
Figure 6. Human Milk Oligosaccharides Report Years Considered
Figure 7. Global Human Milk Oligosaccharides Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Human Milk Oligosaccharides Players Sales Volume Ranking (2024) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Milk Oligosaccharides Revenue in 2024
Figure 10. Human Milk Oligosaccharides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Fucosyllactose Picture
Figure 12. LNT & LNNT Picture
Figure 13. Sialyllactose Picture
Figure 14. Global Human Milk Oligosaccharides Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Human Milk Oligosaccharides Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Human Milk Oligosaccharides Sales Volume by Type (2020 VS 2024 VS 2031) & (K MT)
Figure 17. Global Human Milk Oligosaccharides Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Human Milk Oligosaccharides Price by Type (2020-2031) & (USD/MT)
Figure 19. Product Picture of Infant Formula
Figure 20. Product Picture of Other Applications
Figure 21. Global Human Milk Oligosaccharides Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Human Milk Oligosaccharides Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Human Milk Oligosaccharides Sales Volume by Application (2020 VS 2024 VS 2031) & (K MT)
Figure 24. Global Human Milk Oligosaccharides Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Human Milk Oligosaccharides Price by Application (2020-2031) & (USD/MT)
Figure 26. North America Human Milk Oligosaccharides Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Human Milk Oligosaccharides Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Human Milk Oligosaccharides Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Human Milk Oligosaccharides Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Human Milk Oligosaccharides Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Human Milk Oligosaccharides Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Human Milk Oligosaccharides Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Human Milk Oligosaccharides Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Human Milk Oligosaccharides Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Human Milk Oligosaccharides Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Human Milk Oligosaccharides Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Human Milk Oligosaccharides Sales Volume (%), (2020-2031)
Figure 38. United States Human Milk Oligosaccharides Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Human Milk Oligosaccharides Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Human Milk Oligosaccharides Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Human Milk Oligosaccharides Sales Value by Application (%), 2024 VS 2031
Figure 44. China Human Milk Oligosaccharides Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
Figure 46. China Human Milk Oligosaccharides Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Human Milk Oligosaccharides Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Human Milk Oligosaccharides Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Human Milk Oligosaccharides Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Human Milk Oligosaccharides Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Human Milk Oligosaccharides Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Human Milk Oligosaccharides Sales Value by Application (%), 2024 VS 2031
Figure 56. India Human Milk Oligosaccharides Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Human Milk Oligosaccharides Sales Value by Type (%), 2024 VS 2031
Figure 58. India Human Milk Oligosaccharides Sales Value by Application (%), 2024 VS 2031
Figure 59. Human Milk Oligosaccharides Industrial Chain
Figure 60. Human Milk Oligosaccharides Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Human Milk Oligosaccharides market?
The top companies in the global Human Milk Oligosaccharides market are Abbott、Dupont (Inbiose)、DSM (Glycom).
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Human Milk Oligosaccharides market size from 2025 to 2031?
What was the global market size of Human Milk Oligosaccharides in 2025?
What was the global market size of Human Milk Oligosaccharides in 2031?
Related Reports
Global Human Milk Oligosaccharides Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Milk Oligosaccharides market size was US$ 425 million in 2025 and is forecast to reach a readjusted size of US$ 537 million by 2032 with a CAGR of 3.4% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 76
USD 4250.00
(Single User License)
Global Human Milk Oligosaccharides Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Human Milk Oligosaccharides market is projected to grow from US$ 425 million in 2025 to US$ 537 million by 2032, at a CAGR of 3.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 134
USD 4900.00
(Single User License)
Human Milk Oligosaccharides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Milk Oligosaccharides was estimated to be worth US$ 425 million in 2025 and is projected to reach US$ 537 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 103
USD 3950.00
(Single User License)
Global Human Milk Oligosaccharides Market Research Report 2026
The global Human Milk Oligosaccharides market was valued at US$ 425 million in 2025 and is anticipated to reach US$ 537 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 108
USD 2900.00
(Single User License)
Global Human Milk Oligosaccharides Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Milk Oligosaccharides market size was US$ 412 million in 2024 and is forecast to a readjusted size of US$ 521 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 79
USD 4250.00
(Single User License)
Global Human Milk Oligosaccharides Market Research Report 2025
The global market for Human Milk Oligosaccharides was valued at US$ 412 million in the year 2024 and is projected to reach a revised size of US$ 521 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published Date: 2025-01-21
Pages: 82
USD 2900.00
(Single User License)
Global Human Milk Oligosaccharides Market Insights, Forecast to 2030
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Published Date: 2024-04-26
Pages: 95
USD 4900.00
(Single User License)
Global Human Milk Oligosaccharides Market Research Report 2024
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Published Date: 2024-01-15
Pages: 78
USD 2900.00
(Single User License)
Global Human Milk Oligosaccharides Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Milk Oligosaccharides market size was US$ 425 million in 2025 and is forecast to reach a readjusted size of US$ 537 million by 2032 with a CAGR of 3.4% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 76
USD 4250.00 (Single User License)Global Human Milk Oligosaccharides Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Human Milk Oligosaccharides market is projected to grow from US$ 425 million in 2025 to US$ 537 million by 2032, at a CAGR of 3.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 134
USD 4900.00 (Single User License)Human Milk Oligosaccharides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Milk Oligosaccharides was estimated to be worth US$ 425 million in 2025 and is projected to reach US$ 537 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-03-05
Pages: 103
USD 3950.00 (Single User License)Global Human Milk Oligosaccharides Market Research Report 2026
The global Human Milk Oligosaccharides market was valued at US$ 425 million in 2025 and is anticipated to reach US$ 537 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-03-05
Pages: 108
USD 2900.00 (Single User License)Global Human Milk Oligosaccharides Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Milk Oligosaccharides market size was US$ 412 million in 2024 and is forecast to a readjusted size of US$ 521 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 79
USD 4250.00 (Single User License)Global Human Milk Oligosaccharides Market Research Report 2025
The global market for Human Milk Oligosaccharides was valued at US$ 412 million in the year 2024 and is projected to reach a revised size of US$ 521 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published: 2025-01-21
Pages: 82
USD 2900.00 (Single User License)Global Human Milk Oligosaccharides Market Insights, Forecast to 2030
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Published: 2024-04-26
Pages: 95
USD 4900.00 (Single User License)Global Human Milk Oligosaccharides Market Research Report 2024
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Published: 2024-01-15
Pages: 78
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now